#vaccine research

Vaccine development is proceeding at an unprecedented pace, but could still hit snags on the way to approval.

The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.

People who received the vaccine did, however, show stronger immune responses against the virus.

The race continues to find a way to prevent the most common type of dementia that robs millions of the ability to care for themselves.

Sign-on letter from advocates demands that HIV-positive people not be left out.